Tissue Failure of the Low-Profile Ionescu-Shiley Pericardial Valve in Mitral Position.
- Author:
Chong Whan KIM
1
Author Information
1. Department of Thoracic and Cardiovascular Surgery, College of Medicine, Seoul National University, Korea.
- Publication Type:Original Article
- Keywords:
Bioprosthesis;
Prosthesis, failure;
Mitral valve, replacement
- MeSH:
Bioprosthesis;
Constriction, Pathologic;
Follow-Up Studies;
Glutaral;
Hemodynamics;
Heterografts;
Humans;
Incidence;
Pathology;
Prostheses and Implants;
Tissue Preservation
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1997;30(7):670-676
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The structural failure of the glutaraldehyde-treated xenograft valves has been the primary concern about the limited durability as predicted from the beginning of clinical use, and long-term follow-up has shown a significant incidence of primary tissue failure(PTF) from both biological and mechanical reasons. Twenty-seven patients with the low-profile Ionescu-Shiley valves explanted from mitral position for PTF(Group III) were studied on the patient characteristics and valve pathology, and the results were compared with the matched observations of the Hancock(Group I) and of the standard-profile Ionescu-Shiley valves(Group II). Patients were aged 16 to 56 years(mean, 38.0+/-11.0 years), and the size of the failed mitral bioprosthesis was 30.8+/-1.3 mm. The hemodynamic consequences were stenosis in 29.6%, insufficiency in 44.4%, mixed steno-insufficiency in 14.8%, together with normal function for the rest of patients of prophylactic re-replacement. Pathology revealed calcification with or without tissue damage in 63.0% and tissue damage with or without calcification in 58.1%, in contrast with the observations of predominant tissue damage(76.8%) over calcification in Group I and of calcification(76.1%) over tissue damage in group II. Although dystrophic calcification has long and repeatedly dealt with patient's young age as a determinant of valve durability, such a characteristic evidence was not reached even in patients with calcified valves. Moreover, the prolonged explantation periods from the studied on the previous report suggested strongly yet possibly evolving destructive processes among the valves in the remaining patients, and awaits further follow-up. In conclusion, PTF of the xenograft valves seems to result from more complicated biologic and metabolic reasons as well as more complex mecharical factors than the reported, and newer generation prostheses, with tissue preservation with glutaraldehyde, do not likely to provide decisive improvement in the occurrence of structural failurebioprostheses is generally limited to the highly aged.
